ProQR Therapeutics Axiomer RNA editing platform technology

ProQR scientist working in the lab

Featured blogs, stories and news

  • ProQR Update August 2022

    Community news

    Announced today (August 11, 2022), ProQR will focus exclusively on the development of the Axiomer® RNA editing technology platform across multiple therapeutic areas. This comes following feedback from the European Medicines Agency (EMA) related to ProQR’s sepofarsen for Leber Congenital Amaurosis type 10 (LCA10).

  • Rare Disease Day 2022

    Community news

    On behalf of all ProQRians, happy Rare Disease Day 2022. Both within ProQR and outside, we join the community in raising awareness and trying to generate change for people worldwide living with a rare disease, their families, and supporters.

    28 February 2022 is Rare Disease Day. Rare disease day logo on the top right. Portrait of Maartje living with Usher syndrome on the right. #RareDiseaseDay
  • Building an Inclusive ProQR

    Community news

    At ProQR we strive to create an inclusive culture where everyone is valued for who they are and individual differences and contributions are recognized and appreciated. Therefore, we decided for this Pride Month June 2022, to visually demonstrate our support and acknowledgment of the LGBTQ+ community by changing our logo to incorporate the pride rainbow flag.

    Rainbow image with text We Wish You A Happy Pride Month!